Antifibrotic properties of receptor for advanced glycation end products in idiopathic pulmonary fibrosis

Pulmonary Pharmacology and Therapeutics

Volumn 35, Issue , 2015, Pages 34-41

  Ding, Hui ^a   Ji, XiuHai ^b   Chen, Ruhua ^a   Ma, Tieliang ^a   Tang, Zhiwei ^a   Fen, Yan ^a   Cai, Hourong ^c  

^a JIANGSU UNIVERSITY   (China)

^b Taicang Hospital of Traditional Chinese Medicine   (China)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

EMT; ERK; IPF; RAGE; TGF 1

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BLEOMYCIN; COLLAGEN TYPE 1; PROTEIN C JUN; SMAD2 PROTEIN; SMOOTH MUSCLE ACTIN; TRANSFORMING GROWTH FACTOR; ACTIN; AGER PROTEIN, MOUSE; ALPHA-SMOOTH MUSCLE ACTIN, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE; MOK PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ACTINS; ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; ANTIGENS, NEOPLASM; BLEOMYCIN; COLLAGEN TYPE I; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84955438441     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2015.10.010     Document Type: Article

References (34)

1. M. Selman V.J. Thannickal A. Pardo D.A. Zisman F.J. Martinez J.P. Lynch 3rd Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches Drugs 64 4 2004 405 430
2. American Thoracic Society Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) Am. J. Respir. Crit. Care Med 161 2 Pt 1 2000 646 664
3. T.A. Wynn Integrating mechanisms of pulmonary fibrosis J. Exp. Med 208 7 2011 1339 1350
4. H. Watanabe-Takano K. Takano M. Hatano T. Tokuhisa T. Endo DA-Raf-mediated suppression of the Ras-ERK pathway is essential for TGF-beta1-induced epithelial-mesenchymal transition in alveolar epithelial type 2 cells PloS One 10 5 2015 e0127888
5. L. Zhang Y.X. Ji W.L. Jiang C.J. Lv Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo Braz. J. Med. Biol. Res 48 6 2015 545 552
6. C.E. Barkauskas P.W. Noble Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis Am. J. Physiol., Cell Physiol 306 11 2014 C987 C996
7. L.T. Woods J.M. Camden F.G. El-Sayed M.G. Khalafalla M.J. Petris L. Erb Increased expression of TGF-beta signaling components in a mouse model of fibrosis induced by submandibular gland duct ligation PloS One 10 5 2015 e0123641
8. H.A. Chapman Epithelial-mesenchymal interactions in pulmonary fibrosis Annu. Rev. Physiol 73 2011 413 435
9. J. Chen T. Zeng X. Zhao K. Xiea Y. Bi Z. Zhong Docosahexaenoic acid (DHA) ameliorates paraquat-induced pulmonary fibrosis in rats possibly through up-regulation of Smad 7 and SnoN Food Chem. Toxicol 57 2013 330 337 An international journal published for the British Industrial Biological Research Association
10. J.H. Li W. Wang X.R. Huang M. Oldfield A.M. Schmidt M.E. Cooper Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway Am. J. Pathol 164 4 2004 1389 1397
11. M. Neeper A.M. Schmidt J. Brett S.D. Yan F. Wang Y.C. Pan Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins J. Biol. Chem 267 21 1992 14998 15004
12. A.M. Schmidt S.D. Yan S.F. Yan D.M. Stern The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J. Clin. Invest 108 7 2001 949 955
13. M. Morcos A.A. Sayed A. Bierhaus B. Yard R. Waldherr W. Merz Activation of tubular epithelial cells in diabetic nephropathy Diabetes 51 12 2002 3532 3544
14. S.T. Buckley C. Ehrhardt The receptor for advanced glycation end products (RAGE) and the lung J. Biomed. Biotechnol 2010 2010 917108
15. N. Demling C. Ehrhardt M. Kasper M. Laue L. Knels E.P. Rieber Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells Cell Tissue Res 323 3 2006 475 488
16. P.R. Reynolds S.D. Kasteler M.G. Cosio A. Sturrock T. Huecksteadt J.R.R.A.G.E. Hoidal developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells Am. J. Physiol. Lung Cell. Mol. Physiol 294 6 2008 L1094 L1101
17. H.J. Rozycki Potential contribution of type I alveolar epithelial cells to chronic neonatal lung disease Front. Pediat 2 2014 45
18. J.S. Song C.M. Kang C.K. Park H.K. Yoon S.Y. Lee J.H. Ahn Inhibitory effect of receptor for advanced glycation end products (RAGE) on the TGF-beta-induced alveolar epithelial to mesenchymal transition Exp. Mol. Med 43 9 2011 517 524
19. S. Ohlmeier W. Mazur K. Salmenkivi M. Myllarniemi U. Bergmann V.L. Kinnula Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease Proteom. Clin. Appl 4 1 2010 97 105
20. J.M. Englert L.E. Hanford N. Kaminski J.M. Tobolewski R.J. Tan C.L. Fattman A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis Am. J. Pathol 172 3 2008 583 591
21. L. Ramsgaard J.M. Englert J. Tobolewski L. Tomai C.L. Fattman A.S. Leme The role of the receptor for advanced glycation end-products in a murine model of silicosis PloS One 5 3 2010 e9604
22. J.M. Englert C.R. Kliment L. Ramsgaard P.S. Milutinovic L. Crum J.M. Tobolewski Paradoxical function for the receptor for advanced glycation end products in mouse models of pulmonary fibrosis Int. J. Clin. Exp. Pathol 4 3 2011 241 254
23. M. He H. Kubo K. Ishizawa A.E. Hegab Y. Yamamoto H. Yamamoto The role of the receptor for advanced glycation end-products in lung fibrosis Am. J. Physiol. Lung Cell. Mol. Physiol 293 6 2007 L1427 L1436
24. L.E. Hanford J.J. Enghild Z. Valnickova S.V. Petersen L.M. Schaefer T.M. Schaefer Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE) J. Biol. Chem 279 48 2004 50019 50024
25. K.M. Myint Y. Yamamoto T. Doi I. Kato A. Harashima H. Yonekura RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin Diabetes 55 9 2006 2510 2522
26. L. Wang Y. Wang T. Yang Y. Guo T. Sun Angiotensin-converting enzyme 2 attenuates bleomycin-induced lung fibrosis in mice Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol 36 2 2015 697 711
27. A.S. De Vriese R.G. Tilton S. Mortier N.H. Lameire Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia Nephrol. Dial. Transpl. Off. Publ. Eur. Dial. Transpl. Assoc. Eur. Renal Assoc 21 9 2006 2549 2555
28. J.R. Xia N.F. Liu N.X. Zhu Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats Int. J. Mol. Sci 9 4 2008 638 661
29. M. Selman G. Carrillo A. Estrada M. Mejia C. Becerril J. Cisneros Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern PloS One 2 5 2007 e482
30. A. Garcia-Salido G. Onoro G.J. Melen V. Gomez-Pina A. Serrano-Gonzalez M. Ramirez-Orellana Serum sRAGE as a potential biomarker for pediatric bronchiolitis: a pilot study Lung 193 1 2015 19 23
31. M. Kajikawa A. Nakashima N. Fujimura T. Maruhashi Y. Iwamoto A. Iwamoto Ratio of serum levels of AGEs to soluble form of RAGE is a predictor of endothelial function Diabetes Care 38 1 2015 119 125
32. M. Chilosi V. Poletti A. Zamo M. Lestani L. Montagna P. Piccoli Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis Am. J. Pathol 162 5 2003 1495 1502
33. M. Selman A. Pardo L. Barrera A. Estrada S.R. Watson K. Wilson Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis Am. J. Res. Crit. Care Med 173 2 2006 188 198
34. Y. Zhou J.Y. Lee C.M. Lee W.K. Cho M.J. Kang J.L. Koff Amphiregulin, an epidermal growth factor receptor ligand, plays an essential role in the pathogenesis of transforming growth factor-beta-induced pulmonary fibrosis J. Biol. Chem 287 50 2012 41991 42000